We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Sues FDA Over Exclusivity on Diovan Generics
Mylan Sues FDA Over Exclusivity on Diovan Generics
October 5, 2012
Mylan is suing the FDA over its refusal to grant 180-day exclusivity for the company’s four generic versions of Novartis’ high blood pressure drug Diovan.